Measures of high-density lipoprotein function in men and women with severe aortic stenosis

Anouar Hafiane1, Elda Favari2, Anna E Bortnick3,4

  • 1Department of Medicine, Faculty of Medicine, Research Institute of the McGill University Health Centre, 1001 Boulevard Decarie, Montreal, Québec, H3A 1A1, Canada. anouar.hafiane@mail.mcgill.ca.

Insights

Women with severe aortic stenosis have enhanced cholesterol efflux capacity, suggesting improved reverse cholesterol transport may protect against calcification. These sex-specific differences in high-density lipoprotein function offer insights into aortic valve calcification.

Area of Science:

  • Cardiovascular Research
  • Biochemistry
  • Medical Science

Background:

  • Aortic valve calcification (AVC) is a prevalent heart valve disorder, often progressing to severe aortic stenosis (AS).
  • While sex-specific differences in AVC exist, with women exhibiting lower calcification burden, the underlying mechanisms remain unclear.

Purpose of the Study:

  • To investigate sex-specific differences in high-density lipoprotein (HDL) cholesterol efflux capacity (CEC) in patients with severe AS.
  • To explore the potential role of HDL functionality in explaining sex-based variations in AVC.

Main Methods:

  • HDL particles were isolated from plasma of men and women with severe AS.
  • Cholesterol efflux capacity (CEC) was measured using cultured human THP-1 macrophages and human aortic valve interstitial cells.
  • ATP-Binding Cassette A1 (ABCA1)-mediated HDL-CEC and HDL particle composition (pre-β1 and α-HDL) were analyzed.

Main Results:

  • Women with severe AS demonstrated significantly higher ABCA1-mediated HDL-CEC compared to men.
  • Women exhibited higher levels of pre-β1 and α-HDL particles and increased lecithin-cholesterol acyltransferase (LCAT) activity.
  • These findings suggest enhanced reverse cholesterol transport in women with severe AS.

Conclusions:

  • Significant sex-specific differences in HDL functionality, particularly HDL-CEC, were observed in severe AS patients.
  • Enhanced HDL functionality in women may contribute to their lower burden of aortic valve calcification.
  • Targeting sex-related pathways in AS is crucial for advancing understanding and treatment of this condition.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
44
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
47
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
53
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
304
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
134
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
230